dc.contributor.author |
Nolan, MB
|
|
dc.contributor.author |
Bertschinger, HJ
|
|
dc.contributor.author |
Crampton, Michael
|
|
dc.contributor.author |
Schulman, ML
|
|
dc.date.accessioned |
2018-10-15T11:10:27Z |
|
dc.date.available |
2018-10-15T11:10:27Z |
|
dc.date.issued |
2018-07 |
|
dc.identifier.citation |
Nolan, M.B. et al. 2018. Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares. Journal of Equine Veterinary Science, vol. 66(105): 1pp |
en_US |
dc.identifier.issn |
0737-0806 |
|
dc.identifier.uri |
DOI: https://doi.org/10.1016/j.jevs.2018.05.152
|
|
dc.identifier.uri |
https://www.j-evs.com/article/S0737-0806(18)30356-3/fulltext
|
|
dc.identifier.uri |
http://hdl.handle.net/10204/10463
|
|
dc.description |
Copyright: 2018 Elsevier. Due to copyright restrictions, the attached PDF file only contains the abstract of the full text item. For access to the full text item, please consult the publisher's website. |
en_US |
dc.description.abstract |
Ovarian suppression was recently suggested as an inherent feature of effective zona pellucida (ZP) based immunocontraception across various species including horses. Measuring anti-Müllerian hormone (AMH) in immunocontracepted mares may provide a novel and minimally-invasive tool for the assessment of ovarian function (Joone et al, Theriogenology, 2018, vol. 106(2): 214-220). This study aimed to assess the utility of measuring serum AMH concentrations by comparison with clinical parameters for monitoring ovarian activity following ZP-based immunocontraception in a population of horse mares. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Elsevier |
en_US |
dc.relation.ispartofseries |
Worklist;21381 |
|
dc.subject |
Immunocontraceptive vaccination |
en_US |
dc.subject |
Mares |
en_US |
dc.subject |
Serum anti-Müllerian Hormone |
en_US |
dc.subject |
Zona Pellucida |
en_US |
dc.title |
Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares |
en_US |
dc.type |
Article |
en_US |
dc.identifier.apacitation |
Nolan, M., Bertschinger, H., Crampton, M., & Schulman, M. (2018). Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares. http://hdl.handle.net/10204/10463 |
en_ZA |
dc.identifier.chicagocitation |
Nolan, MB, HJ Bertschinger, Michael Crampton, and ML Schulman "Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares." (2018) http://hdl.handle.net/10204/10463 |
en_ZA |
dc.identifier.vancouvercitation |
Nolan M, Bertschinger H, Crampton M, Schulman M. Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares. 2018; http://hdl.handle.net/10204/10463. |
en_ZA |
dc.identifier.ris |
TY - Article
AU - Nolan, MB
AU - Bertschinger, HJ
AU - Crampton, Michael
AU - Schulman, ML
AB - Ovarian suppression was recently suggested as an inherent feature of effective zona pellucida (ZP) based immunocontraception across various species including horses. Measuring anti-Müllerian hormone (AMH) in immunocontracepted mares may provide a novel and minimally-invasive tool for the assessment of ovarian function (Joone et al, Theriogenology, 2018, vol. 106(2): 214-220). This study aimed to assess the utility of measuring serum AMH concentrations by comparison with clinical parameters for monitoring ovarian activity following ZP-based immunocontraception in a population of horse mares.
DA - 2018-07
DB - ResearchSpace
DP - CSIR
KW - Immunocontraceptive vaccination
KW - Mares
KW - Serum anti-Müllerian Hormone
KW - Zona Pellucida
LK - https://researchspace.csir.co.za
PY - 2018
SM - 0737-0806
T1 - Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares
TI - Serum anti-Müllerian hormone following Zona Pellucida immunocontraceptive vaccination of mares
UR - http://hdl.handle.net/10204/10463
ER -
|
en_ZA |